Irrespective of its shortcomings, The reality that the coverage is staying rolled out as being a demo is usually a good issue, reckons Michel Kazatchkine, a member of the Global Commission on Drug Coverage. The strongest strategy to encourage naysayers is through supplying cold, tricky, irrefutable proof, he claims, and The easiest method to do tha